Selective dopamine depletion within the medial prefrontal cortex induces anxiogenic-like effects in rats placed on the elevated plus maze

Brain Research

Volumn 762, Issue 1-2, 1997, Pages 281-284

  Espejo, Emilio Fdez ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

6 Hydroxydopamine; Anxiety; Dopamine; Elevated plus maze; Locomotion; Prefrontal cortex; Rat

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; NORADRENALIN; OXIDOPAMINE; SEROTONIN;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; ATTENTION; COGNITION; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; LOCOMOTION; MALE; MAZE TEST; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; THALAMUS DORSOMEDIAL NUCLEUS;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DENERVATION; DOPAMINE; MALE; MAZE LEARNING; MICROINJECTIONS; OXIDOPAMINE; PREFRONTAL CORTEX; RATS; RATS, WISTAR; SYMPATHOLYTICS;

EID: 0030798031     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00593-3     Document Type: Article

References (23)

1. Bean A.J., Roth R.H. Effects of haloperidol administration on in vivo extracellular dopamine in striatum and prefrontal cortex after partial dopamine lesions. Brain Res. 549:1991;155-158.
2. Beracochea D., Krazem A. Effects of mammillary body and mediodorsal thalamic lesions on elevated plus maze exploration. NeuroReport. 2:1991;793-796.
3. A. Björklund, O. Lindvall, Dopamine-containing systems in the CNS, in: A. Björklund, T. Hökfelt (Eds.), Classical Transmitters in the CNS, Elsevier, Amsterdam, 1984, pp. 55-122.
4. Blanchard R.J., Blanchard D.C. Attack and defense in rodents as ethoexperimental models for the study of emotion. Prog. Neuropsychopharmacol. Biol. Psychiatry. 13:1989;S3-S14.
5. Carter C.J., Pycock C.J. Lesions of the frontal cortex of the rat: changes in neurotransmitter systems in sub-cortical regions. Br. J. Pharmacol. 64:1978;430.
6. Carter C.J., Pycock C.J. Behavioral and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat. Brain Res. 192:1980;163-176.
7. Cruz A.P., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus maze. Pharmacol. Biochem. Behav. 49:1993;171-176.
8. Dawson G.R., Tricklebank M.D. Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol. Sci. 16:1995;33-36.
9. S.E. File, Behavioural detection of anxiolytic action, in: J.M. Elliot, D. Heal, C.A. Marsden (Eds.), Experimental Approaches to Anxiety and Depression, Wiley, Chichester, 1992, pp. 25-44.
10. Handley S.L., Mithani S. Effects of α-adrenoceptor agonists and antagonists in a maze-exploration model of "fear"-motivated behaviour. Naunyn-Schmiedeberg's Arch. Pharmacol. 327:1984;1-5.
11. Heffner T.G., Hartman J.A., Seiden L.S. A rapid method for the regional dissection of the rat brain. Pharmacol. Biochem. Behav. 13:1980;453-456.
12. Herman J.P., Guillonneau D., Dantzer R., Scatton B., Smerdjian-Rouquier L., Le Moal M. Differential effects of inescapable footshocks and of stimuli previously paired with inescapable footshocks on dopamine turnover in cortical and limbic areas of the rat. Life Sci. 30:1982;2207-2214.
13. Kaesermann H.P. Stretched attended posture, a non-social form of ambivalence, is sensitive to a conflict-reducing drug action. Psychopharmacology (Berlin). 89:1986;31-37.
14. Lavielle S., Tassin J.P., Thierry A.M., Blanc G., Herve D., Barthelemy C., Glowinski J. Blockade by benzodiazepines of the selective high increase in dopamine turnover induce by stress in mesocortical dopaminergic neurons of the rat. Brain Res. 168:1979;585-594.
15. Le Moal M., Simon H. The mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol. Rev. 71:1991;155-234.
16. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berlin). 92:1987;180-185.
17. Lister R.G. Interactions of three benzodiazepine receptor inverse agonists with ethanol in a plus maze test of anxiety. Pharmacol. Biochem. Behav. 30:1988;701-706.
18. Motta V., Brandao M.L. Aversive and antiaversive effects of morphine in the dorsal periaqueductal gray of rats submitted to the elevated plus maze. Pharmacol. Biochem. Behav. 44:1993;119-125.
19. Pesold C., Treit D. Excitotoxic lesions of the septum produce anxiolytic effects in the elevated plus maze and shock-probe burying tests. Physiol. Behav. 52:1992;37-47.
20. Pycock C.J., Kerwin R.W., Carter C.J. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature. 286:1980;74-77.
21. R.J. Rodgers, J.C. Cole, The elevated plus-maze: pharmacology, methodology and ethology, in: S.J. Cooper, C.A. Hendrie (Eds.), Ethology and Psychopharmacology, Wiley, New York, 1994, pp. 9-44.
22. Taylor D.P., Riblet L.A., Stanton H.C., Eison A.S., Eison M.S., Temple D.L. Dopamine and antianxiety activity. Pharmacol. Biochem. Behav. 17:1982;25-35.
23. Wada T., Fukuda N. Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in the elevated plus maze. Psychopharmacology (Berlin). 104:1991;444-450.